Anticoagulant therapy does not extend survival in people with PAH, according to a French study involving the blood thinners.

Death rates and disability in newborn PAH have declined globally since 1990, but inequalities remain, according to a 30-year ...

The term "October slide" refers to a trend in which many in the chronic illness community face health setbacks, writes ...

Experimental treatment ALG-801 was shown to be more effective than approved PAH therapies at reducing signs of disease in an ...

The strategy begins with medications, followed by balloon pulmonary angioplasty, and pulmonary endarterectomy surgery, a ...

Long-term treatment with Tyvaso DPI is safe and effective in adults with PAH who were previously on Tyvaso, according to ...

Researchers developed PVC, a measure that estimates the reduced function of the pulmonary arteries in pediatric PAH patients, per a study.

Winrevair (sotatercept-csrk), when added to standard of care, reduced clinical worsening events by 76% in adults recently diagnosed with pulmonary arterial hypertension (PAH). “These positive results ...

When pulmonary hypertension (PH) crashed over me, it caused me to mourn the loss of my health, my life’s work, and my dreams. It left me with a crazy mess of grief. I remember telling myself, day in ...

Stem cell-derived conditioned medium, or the liquid that remains after cells are cultured, reduces the signs of pulmonary arterial hypertension (PAH) in rat and cell models, a study showed. “These ...